Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Gelteq Ltd changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 80.9K | 105.1K | +24.2K (+29.9%) |
| Value | $187.5K | $107.6K | −$79.9K (−42.6%) |
New holders (2)
Institutions that held Gelteq Ltd at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 10,772 | $11.2K | 0.00% |
| Morgan Stanley | 3,500 | $3.64K | 0.00% |
Sold out (0)
Institutions that held Gelteq Ltd at the end of Q4 2024 and filed for Q1 2025 without it.
None.